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In Brief
Perforin-positive dendritic cells (perf-
DCs) represent a minor subpopulation of
myeloid DCs. Based on selective ablation
of perf-DCs in radiation chimera, Reisner
and colleagues demonstrate that these
cells control inflammatory T cells in
steady state and play a regulatory role in
metabolic syndrome and in experimental
autoimmune encephalomyelitis.
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Emerging evidence suggests that immunological
mechanisms underlie metabolic control of adipose
tissue. Here, we have shown the regulatory impact
of a rare subpopulation of dendritic cells, rich in
perforin-containing granules (perf-DCs). Using bone
marrow transplantation to generate animals selec-
tively lacking perf-DCs, we found that these chi-
meras progressively gained weight and exhibited
features of metabolic syndrome. This phenotype
was associated with an altered repertoire of T cells
residing in adipose tissue and could be completely
prevented by T cell depletion in vivo. A similar impact
of perf-DCs on inflammatory T cells was also found in
a well-defined model of multiple sclerosis, experi-
mental autoimmune encephlalomyelitis (EAE). Thus,
perf-DCs probably represent a regulatory cell sub-
population critical for protection frommetabolic syn-
drome and autoimmunity.
INTRODUCTION
Studies of cellular mechanisms involved in maintenance of pe-
ripheral immune tolerance have largely focused on T regulatory
(Treg) cells, but other key cellular mediators such as B regulatory
(B reg) cells, myeloid suppressor cells (MDSCs), and various
types of dendritic cells (DCs) have been implicated, as well.
DCs have a tolerogenic capacity in their immature state (Dho-
dapkar et al., 2001; Fu et al., 1996; Jonuleit et al., 2000; Lutz
et al., 2000; Tiao et al., 2005; Trinite´ et al., 2005). However, this
rather simplistic dichotomy between mature and immature
DCs has been challenged by the demonstration that fully mature
DCs can also induce tolerance under appropriate conditions (Lu
et al., 1997; Su¨ss and Shortman, 1996;Waithman et al., 2007; Yu
et al., 2009).
We have recently described the generation of a highly defined
population of DCs from LinSca1+cKit+ (LSK) hematopoietic
progenitors (Zangi et al., 2012). These DCs express perforin
and granzyme A in discrete granules and are therefore termed776 Immunity 43, 776–787, October 20, 2015 ª2015 Elsevier Inc.‘‘perf-DCs’’ (Zangi et al., 2012). Perf-DCs are able to selectively
kill cognate T cell receptor (TCR) transgenic CD8+ T cells that
recognize their peptide-MHC, through a unique perforin and
granzyme A-based killing mechanism, regulated through toll-
like receptor-7 (TLR7) and triggering receptor expressed on
myeloid cells-1 (TREM-1) signaling (Zangi et al., 2012). We
demonstrated by immune histological staining that perf-DCs
comprise about 2%–4% of the CD11c-positive cells within the
lymph nodes and spleen and that the abundance of these cells
is markedly enhanced upon in vivo administration of granulocyte
macrophage colony stimulating factor (GM-CSF) (Zangi et al.,
2012).
Perforin-positive myeloid DCs have also been reported within
the human classical DC population (Stary et al., 2007). These
initial findings, based exclusively on ex vivo studies, indicated
a potential tolerogenic role for perf-DCs; however, the relevance
of this cell population to tolerance maintenance in the steady
state in vivo remained unresolved.
To address this question, we used bone marrow transplan-
tation to generate chimeric mice, in which perforin expression
is selectively impaired in CD11c-positive DCs. We found
that, within 5 months, these mice developed many features
of metabolic syndrome, suggesting that perf-DCs represent
an important regulatory population that might control inflam-
matory processes in the adipose tissue (AT). Our results are
in line with the emerging intriguing cross-talk between the
immune system and the endocrine AT (Hotamisligil et al.,
1993; Weisberg et al., 2003; Xu et al., 2003). Specifically,
these studies suggest that AT dysfunction and metabolic im-
balances in obesity are associated with low-grade systemic
inflammation.
The antigens that drive AT-specific T cell selection and
expansion resulting in the observed AT inflammation are not
yet known. We therefore investigated the regulatory role of
perf-DCs in a more defined model of autoimmunity, namely
experimental autoimmune encephalomyelitis (EAE). In line
with our hypothesis that perf-DCs have immuno-regulatory ac-
tivity, mice lacking these cells were substantially more prone to
induction of EAE, exhibiting significantly elevated autoimmune
T cell clones compared to their WT counterparts. Collectively,
we demonstrate that perf-DCs mediate a key role in steady-
state protection from development of metabolic syndrome, as
well as in the control of EAE.
Figure 1. Characterization of Donor Type
Origin in Immune Cells of WT-Prf1–/– and
Itgax-DTA-Prf1–/– Chimeras
(A) Flow cytometry analysis of CD11c+ cells from
spleen of Itgax-DTA-Prf1/ chimeric mice and
WT-Prf1/ controls. The CD11c+ cells could be
divided into CD11chi (cDCs) and CD11cint sub-
populations.
(B) cDC expression in the spleen of Itgax-
DTA-Prf1/ and WT-Prf1/ chimeras. Error bars
represent mean ± SD.
(C) The cells defined in (A) were further stained for
CD45.1 to identify cell origin from Itgax-DTA mice
or littermate controls, or for CD45.2 expressed
by Prf1/ donors. Numbers indicate percent of
CD45.1 cells in the various populations (mean ±
SD, nR 5).
(D and E) Donor origin as defined by flow cytometry
analysis of CD45.1 and CD45.2 of BM pre-DCs (D),
B cells, NK cells, pDCs, T cells, and neutrophils
(E) from Itgax-DTA-Prf1/ chimeric mice and
WT-Prf1/ controls 2 months after transplant.
These percentages indicate the frequencies of
each subpopulation out of the entire lymphogate in
the organ (spleen or BM).
See also Table S1 and Figure S1.RESULTS
Characterization of Perf-DCs in Radiation Chimeras
As previously described (Zangi et al., 2012), perf-DCs represent
a minor subpopulation (4%) within the CD11c+ population in
the spleen of WT C57BL/6 mice (Figure S1A). This rare subpop-
ulation of perf-DCs is markedly enhanced upon in vivo adminis-
tration of GM-CSF (Zangi et al., 2012), and to a lesser extent,
upon treatment with Flt3L (data not shown). Furthermore, as
shown in Figure S1B, perforin is expressed in CD11chiMHC-IIhi
DCs but not in CD11cint macrophages identified by their F4/80
expression and by their inability to effectively stimulate T cells.
To evaluate the functional role of perf-DCs in the steady state
in vivo, we generated mice that selectively lack perforin expres-
sion in CD11chi DCs. Chronic selective ablation of these cells
can be attained in transgenic mice expressing the diphtheria
toxin (DTx) A subunit (DTA) under control of a CD11c promoter
(CD11cCre:R26-STOP-DTA mice [Birnberg et al., 2008]). Of
note, most macrophages, NK cells, and pDCs, expressing lowImmunity 43, 776–787to intermediate CD11c, are spared in
these mice (Birnberg et al., 2008). To
induce a restricted perforin deficiency
within the CD11chi DC population, we
generated bone marrow (BM) chimeras
using a 1:1 mixture of Prf1/ BM (Ka¨gi
et al., 1994) and BM of mice expressing
diphtheria toxin alpha chain (DTA) in
CD11chi cells (Itgax-DTA mice) (Birnberg
et al., 2008). Based on the reported prop-
erties of the Itgax-DTA mice (Birnberg
et al., 2008), cells other than CD11chi
DCs will be derived in the resulting chi-
meras (Itgax-DTA-Prf1/), from both
types of donor BM (and hence 50% willexpress perforin). In contrast, due to the DTA-mediated ablation
of perforin-proficient cells, the CD11chi population will be exclu-
sively derived from the Prf1/ donor and therefore lack perforin.
These chimeras should thereby allow us to determine whether
the absence of perf-DCs leads to a particular autoimmune
phenotype, similarly to that found in mice lacking other immune
regulatory cells (Sakaguchi, 2000). In parallel, we generated
control BM chimeras by transplantation of a 1:1 mixture of
BM from Prf1/ mice and BM from Itgax-DTA-negative litter-
mates (WT-Prf1/ mice). Histological evaluation via ImageJ
software of cDCs isolated from spleens of Itgax-DTA-Prf1/
chimeras confirmed absence of perforin-expressing DCs
(0.09% ± 0.19%), whereas in WT-Prf1/ chimera the expres-
sion of perf-DCs was reduced to 2.4% ± 1.9% from 4.1% ±
1% found in WT mice (data not shown).
Confirming our ablation strategy, CD11chiMHC-IIhi cDCs (Fig-
ure 1A), although reaching the same steady-state expression
as in the WT-Prf1/ chimera (Figure 1B), were exclusively
derived from the CD45.2+ Prf1/ donor (Figure 1C). Likewise,, October 20, 2015 ª2015 Elsevier Inc. 777
Figure 2. Itgax-DTA-Prf1–/– Mice Develop a
Condition Resembling Metabolic Syndrome
at 6 Months after Transplant
(A) Body weight of chimeric mice 6 months after
transplant. Data pooled from three independent
experiments (nR 18).
(B) Kinetics of weight gain in Itgax-DTA-Prf1/
(gray curve) and WT-Prf1/ (black curve) mice.
Error bars represent mean ± SD.
(C) Blood chemistry profile of the chimeric mice
(mean ± SD, nR 6, *p < 0.05, ***p < 0.001).
(D and E) Serum leptin (D) and TNF-a (E) amounts
in the Itgax-DTA-Prf1/ and control WT-Prf1/
chimeras (mean ± SD, nR 5).
(F) Percent body fat measured via EchoMRI. Error
bars represent mean ± SD; *p < 0.05, ***p < 0.001
(open bar, Itgax-DTA-Prf1/; closed bar, WT-
Prf1/).
Data are representative of three (A–D) or two (E and
F) independent experiments. See also Figure S2.BM pre-DCs largely originated from the CD45.2+ Prf1/
donor (Figure 1D). In contrast, WT-Prf1/ chimeras exhibited
CD11chi cells that were equally derived from both BM donors
(Figure 1D). Notably, T cells, B cells, neutrophils, pDCs, NK cells,
and macrophages in the spleen of Itgax-DTA-Prf1/ chimeras
were equally derived from both BM donors (Figure 1E, Table
S1). These results establish that Itgax-DTA-Prf1/ chimeras,
in which all CD11chi DCs are derived from Prf1/ donors, and
thus do not express perforin, offer a robust model for studying
the role of perf-DCs in the steady state.
Perf-DC-Deficient Chimeras Develop Metabolic
Syndrome
After the generation of Itgax-DTA-Prf1/ chimeras, these mice
were followed for a prolonged period to assess the development
of a potential pathological phenotype that might be associated
with the lack of perf-DCs. Itgax-DTA-Prf1/ chimeric mice
spontaneously gained significantly more weight compared to778 Immunity 43, 776–787, October 20, 2015 ª2015 Elsevier Inc.their WT-Prf1/ counterparts, starting
at 5 months after transplant (Figures
2A and 2B). A similar difference was
found when comparing the animals to
an additional control group in which
recipient mice received mixed BM from
WT and Itgax-DTA donors (Itgax-DTA-
WT) (Figure S2). The increased weight
gain observed in Itgax-DTA-Prf1/ mice
prompted us to test whether this phe-
nomenon was accompanied by meta-
bolic alterations. Indeed, we detected
dyslipidemia in the Itgax-DTA-Prf1/
mice, manifested by elevated serum
cholesterol and triglycerides in com-
parison to those exhibited by the con-
trols (Figure 2C). In addition, the percent
of total body fat, as measured by
body composition MRI, was signifi-
cantly elevated in Itgax-DTA-Prf1/
mice compared to both control groups(Figure 2). Itgax-DTA-Prf1/mice, but not the control chimeras,
displayed highly elevated TNF-a (linked to obesity-associated
inflammation and insulin resistance) (Hotamisligil et al., 1993)
and leptin, the proinflammatory adipokine associated with
obesity, overeating, hypertension, cardiovascular diseases,
and metabolic syndrome (Figures 2D–2F; Ouchi et al., 2011).
Furthermore, Itgax-DTA-Prf1/ chimeric mice exhibited
decreased ability to handle glucose challenge (assessed by
glucose-tolerance test [GTT]) (Figure 3A), as well as reduced
insulin sensitivity (determined by insulin-tolerance test [ITT])
(Figure 3B). Taken together, these findings support a tendency
of Itgax-DTA-Prf1/ chimeric mice to develop type 2 diabetes
and a general condition resembling metabolic syndrome.
In healthy individuals, AT expansion occurs by enlargement
of the fat pad mass through enhanced recruitment of adipo-
cyte precursor cells that differentiate into small adipocytes,
along with the recruitment of other stromal cell types. Subse-
quently, vascularization, minimal induction of extracellular matrix
Figure 3. Typical Features of Type 2 Diabetes and Adipose Tissue
Expansion in Itgax-DTA-Prf1–/– Mice
(A and B) Glucose homeostasis determined by glucose-tolerance test (A)
and insulin-tolerance test (B) in Itgax-DTA-Prf1/ (red) or WT-Prf1/ (black)
chimeric mice, demonstrating impaired glucose tolerance and reduced insulin
sensitivity. Mice (nR 6 per group) were injected i.p. with 2 g glucose/kg body
weight (BW) (A) or with 0.75 U insulin/kg BW (B), and plasma glucose was
measured at the indicated time points. Mean ± SEM; statistical analysis was
performed with GraphPad Prism software by repeated-measurements two-
way ANOVA, followed by Bonferroni post hoc analysis; *p < 0.05, ***p < 0.001.
(C) Mean size of adipocytes in Itgax-DTA-Prf1/ versusWT-Prf1/mice. The
surface area of at least 100 adipocytes per image was counted, and a total of
five images per epydidimal fat pad were analyzed by ImageJ software.
Number of mice per groupR 3. Error bars represent mean ± SD.
(D) Number of CLSs per surface unit.
(E) Representative H&E staining of epydidimal fat pad from each group. Scale
bars represent 50 mm.
Data are representative of three (A, B) or two (C, D) independent experiments.(ECM), andminimal inflammation occur. In contrast, pathological
expansion of AT is characterized by rapid growth of the fat pad
through enlargement of existing fat cells, pronounced macro-
phage infiltration, limited vessel development, and massive
fibrosis. Such pathological expansion is associated with chronic
inflammation, ultimately resulting in the development of systemic
insulin resistance (Sun et al., 2011). The observedmetabolic syn-
drome in Itgax-DTA-Prf1/ chimeras indicated that pathological
AT expansion might occur in these mice. Indeed, as seen in Fig-
ures 3C–3E, adipocytes in the AT tissue of Itgax-DTA-Prf1/
chimeras were larger, less organized, and more loosely packed
compared to adipocytes in WT-Prf1/ control chimeras. More-over, the visceral AT of Itgax-DTA-Prf1/ chimeras contained
more ‘‘crown-like’’ structures (CLSs), which are formed when
macrophages within inflamed AT cluster around dead adipo-
cytes (Figures 3C–3E; Cildir et al., 2013).
CD4+ and CD8+ T Cells Are Required for Development of
Metabolic Syndrome in Itgax-DTA-Prf1–/– Chimeras
To define candidate effector cells that might be controlled
by perf-DCs, we initially analyzed immune cell populations in
collagenase-digested stromal vascular fractions (SVF) from
epididymal adipose tissue, as previously described (Brake
et al., 2006).
WT-Prf1/ and Itgax-DTA-Prf1/ chimeras exhibited similar
distributions of four subpopulations—CD11chiCD11bhi (I),
CD11chiCD11bint (II), CD11cintCD11bhi (III), and CD11cintCD11bint
(IV) cells in the AT—similar to the ones described above for the
spleen. Although these subpopulations residing in the AT might
differ in function and origin from the splenic cells bearing the
same phenotypes, no significant difference in the frequencies of
the CD11chi DCs was found between the two types of chimera
(Figure S3). However, as shown in Figures 4A and 4B, AT of
Itgax-DTA-Prf1/ mice displayed significantly more CD4+ and
CD8+ T cells compared toWT-Prf1/ chimeras at 6 months after
transplant, the timeofdiseaseonset, althoughnodifferenceswere
found inneutrophil ormacrophagenumbers (FigureS3), nor inBor
Treg cells (Figures 4C and 4D).
Because immune cell composition differed mainly in the T cell
compartment, we further investigated the potential roles of CD4+
and CD8+ T cells by ablating these cell subpopulations prior
to disease onset in the Itgax-DTA-Prf1/ chimera. Because a
developing inflammatory response was detected within the AT
tissue based on cell composition (i.e., expansion of CD4+ and
CD8+ T cells) and serum markers (leptin, TNF-a, IL-1b) starting
at5monthsafter transplant,weadministeredweekly i.p. injections
of anti-CD4 antibodies, anti-CD8 antibodies, or both, starting
1 month prior to development of the earliest inflammatory signs
(4th month after BM transplant). This treatment resulted in more
than 95% depletion of the target population(s) in the spleen, LNs,
and peripheral blood, with no changes in other cell populations
(data not shown). More importantly, though, we found that Itgax-
DTA-Prf1/ mice treated with anti-CD4 antibodies, anti-CD8
antibodies, or a combination of them did not gain weight, similar
to the WT-Prf1/ controls (Figure 4E). Likewise, serum leptin
was found to be elevated only in the group of Itgax-DTA-Prf1/
mice not treated with antibody (Figure 4F). This observed role of
both CD4+ and CD8+ T cells is consistent with potential triggering
of the AT pathology by effector CD8+ T cells requiring initial help
from CD4+ T cells.
Because alterations in central regulatory functions are prob-
ably involved in the metabolic changes observed, and recent
data demonstrate changes in inflammatory status in the hypo-
thalamus that might be important in body weight regulation,
we evaluated the expression of interleukin-6 (IL-6) and IL-1b in
the hypothalamus of Itgax-DTA-Prf1/ and control WT-Prf1/
chimeric mice before (4 months after transplant) and after
(9 months after transplant) disease onset. We found that these
cytokines were indeed elevated in Itgax-DTA-Prf1/ chimera,
albeit only after disease onset. Thus, although there was no sig-
nificant difference at 4 months, by 9months after transplantationImmunity 43, 776–787, October 20, 2015 ª2015 Elsevier Inc. 779
Figure 4. Elevated T Cell Numbers within AT
of Itgax-DTA-Prf1–/– Mice 6 Months after
Transplant; Systemic CD8+ and CD4+ Deple-
tion Prevents Weight Gain and Increase in
Leptin
SVF cells isolated from VAT of Itgax-DTA-Prf1/
(white bars) and WT-Prf1/ (black bars) mice
maintained on a normal diet for 6 months were
subjected to FACS analysis.
(A) Dot plots showing CD4+ and CD8+ T cells after
gating out CD11b cells.
(B–D) Absolute numbers of CD4+ and CD8+ T cells
(B), Treg cells (C), and B cells (D) were determined
per gram of fat tissue (mean ± SD; *p < 0.05, nR 5).
(E) Itgax-DTA-Prf1/ and WT-Prf1/ mice were
treated with weekly i.p. injections of anti-CD4
(black triangle), anti-CD8 (black square), or both
antibodies (black circle). The control animals
were treated with weekly injections of PBS (red
diamond). The weight changes were monitored
weekly and calculated as the percent of initial
weight (mean ± SD; *p < 0.05).
(F) Leptin concentrations were measured by ELISA
(mean ± SD; ***p < 0.001).
Data are representative of two replicates. See also
Figure S3.IL-6 was four times higher in Itgax-DTA-Prf1/ mice compared
to WT-Prf1/ mice (p < 0.01), and IL-1b was six times higher in
Itgax-DTA-Prf1/ mice compared to WT-Prf1/ mice (p <
0.05), indicating that these changes might be induced as a result
of the inflammatory process in AT.
The T Cell Repertoire Is Modified within the Adipose
Tissue of Itgax-DTA-Prf1–/– Chimeras
It is possible that autoimmune T cells are poorly controlled in the
absence of regulatory perf-DCs. To address this possibility, the
TCR repertoire from AT tissue of Itgax-DTA-Prf1/ and WT-
Prf1/ chimeras at 6 months after transplant was analyzed by
high-throughput TCR sequencing (Ndifon et al., 2012). We
sequenced the TCRb CDR3 region of T cells and compared
the repertoire found in spleen, visceral AT (VAT), and subcutane-
ous AT (SC-AT) of Itgax-DTA-Prf1/ and WT-Prf1/ chimeras.
As a measure of the composition of the TCR repertoire, we
evaluated the degree of skewing in the frequencies of observed
TCR sequences. A more diverse repertoire consists of se-780 Immunity 43, 776–787, October 20, 2015 ª2015 Elsevier Inc.quences that are found at similar fre-
quencies, whereas in a skewed reper-
toire, a small number of sequences are
dominant and are found at higher fre-
quencies. The skewing of a repertoire
can be evaluated by the increased devia-
tion of its Lorentz curve from the diagonal.
We first compared the repertoires of
T cells resident within AT to the repertoire
found in the spleen of WT-Prf1/ ani-
mals. Consistent with previous observa-
tions of a restricted TCR repertoire within
AT (Feuerer et al., 2009;Winer et al., 2009;
Yang et al., 2010), we observed greater
skewing in the repertoires of T cellsderived from VAT and SC-AT compared with splenic T cells of
WT-Prf1/mice (Figure 5A). We also identified specific Vb seg-
ments that were enriched in the repertoires derived from AT
compared with the splenic repertoire. Next, we compared the
TCR repertoires between WT-Prf1/ and Itgax-DTA-Prf1/
chimeras. Although there was no difference in the spleens of
these chimeras, the TCR repertoire observed in the AT tissues
derived from Itgax-DTA-Prf1/ mice was less skewed than
that of theWT-Prf1/mice (Figure 5A). Thus, the TCR repertoire
in AT of the WT-Prf1/ chimera is dominated by expansion of a
small number of clonotypes, whereas the Itgax-DTA-Prf1/ AT
repertoire contains a greater number of distinct T cell clones with
intermediate expression. To identify signature TCR sequences
that distinguish the two types of chimera, we used an ordination
method, similar to principal-component analysis (Yeung and
Ruzzo, 2001), termed redundancy analysis (RDA) (Sadys et al.,
2015). This method attempts to explain the variance in the
data, constrained by the grouping of samples, by fitting a linear
model that maximizes the variance between groups. With RDA,
Figure 5. A Modified TCR Repertoire in
Adipose Tissues from Itgax-DTA-Prf1–/–
Mice Compared with WT-Prf1–/– Mice
(A) Lorenz representation of the TCRb repertoire
skewing for T cells from spleen, VAT, and SC-AT
of Itgax-DTA-Prf1/ (blue) and WT-Prf1/ (red)
mice. For each mouse, clonotypes were ordered
by frequency. The cumulative frequency was then
calculated at each rank (normalized to sample
size). The curves represent the mean for each
experimental group.
(B) Redundancy analysis (RDA) is an extension of
principal-component analysis (PCA) that explicitly
models response variables (most abundant CDR3
AA sequences, here) as a function of explanatory
variables: sample type, mouse (Itgax-DTA-Prf1/
or WT-Prf1/), and tissue (spleen, VAT, SC-AT),
in this case. This analysis separates between
repertoires of Itgax-DTA-Prf1/ (blue) versus
WT-Prf1/ (red) along RDA1, and between most
spleen samples (triangles) versus adipose tissue
samples (circles, SC; squares, VAT) along RDA2.
(C) RDA analysis identifying the CDR3 sequences
that are most highly enriched in repertoires of
perforin KO mice compared with WT. 16 CDR3b
sequences with the lowest (negative) weights on
RDA1. These clones were enriched in Itgax-DTA-
Prf1/ mice (blue, n = 3; all three tissues are
shown for each mouse) compared with WT mice
(red, n = 2).
See also Figure S4.we selected TCR sequences with the highest contribution to the
separation between the experimental groups, resulting in a list of
signature sequences that were highly expressed in one group
but not in the other. This analysis separated repertoires of Itgax-
DTA-Prf1/ versus WT-Prf1/ mice along the first RDA axis
(RDA1), and between most spleen samples versus VAT samples
along RDA2 (Figure 5B). Next, we identified CDR3 sequences
that weremost highly enriched in repertoires of Itgax-DTA-Prf1/
mice compared with WT-Prf1/, by RDA analysis. Figure 5C
shows16CDR3baminoacid sequenceswith the lowest (negative)
weights onRDA1, whichwere enriched in Itgax-DTA-Prf1/mice
compared with WT-Prf1/mice. Several TCRb sequences were
consistently upregulated across Itgax-DTA-Prf1/ animals, sug-
gesting their potential role in the observed phenotype. Of note,
many of these TCRs are encoded by different nucleotide se-
quences in different animals (Figure S4), an indication of clonal
selection driven by TCR specificity. These TCR sequences, which
exist in the Itgax-DTA-Prf1/ but not in the WT-Prf1/ animals,
might be mechanistically related to the metabolic phenotype,
though further studies are required to identify the specificity of
the TCRs that distinguish the two types of chimeras.
Itgax-DTA-Prf1–/– Chimeras Develop Enhanced Obesity
in Response to a High-Fat Diet
To learn howmice lacking perf-DCs respond to excess adiposity,
we used a classical model of obesity, in which mice are chroni-Immunity 43, 776–787cally fed a high-fat diet (HFD). When fed
HFD, normal WT C57BL/6 mice develop
glucose intolerance and insulin resistanceby the 12th week, with elevated pro-inflammatory cytokines and
adipokines. Itgax-DTA-Prf1/mice have a tendency to sponta-
neously develop these symptoms, so we followed the dynamics
of metabolic and functional changes at early time points. As can
be seen in Figures 6A and 6B, Itgax-DTA-Prf1/ mice gained
weight much earlier than WT-Prf1/ chimeras when fed HFD,
with higher percentage of body fat, increased liver weight, and
epididymal fat pad weight (Figures 6C–6E).
Furthermore, serum leptin was significantly higher as early as
1 month after initiation of HFD. At 1.5 months from initiation of
feeding, insulin and both IL-1b and tumor necrosis factor-a
(TNF-a) were elevated in Itgax-DTA-Prf1/ mice (Figures 6F–
6H and 6L). Plasma cholesterol and triglycerides were elevated
in Itgax-DTA-Prf1/ mice relative to control WT-Prf1/ ani-
mals, starting at 1 month from initiation of HFD (Figure 6F), and
liver TGs were also markedly higher (Figures 6I–6K). Thus, the
increased susceptibility to diet-induced obesity could offer an
additional, more rapid model for investigating the impact of
perf-DCs on different immune cell subpopulations.
As in the normal-fat diet, we also found that larger numbers
of both CD8+ and CD4+ T cells infiltrated the VAT in Itgax-DTA-
Prf1/ mice fed with HFD compared to controls (Figure S5).
Although therewasnosignificantelevationofmacrophageswithin
theVATof the Itgax-DTA-Prf1/chimera (FigureS5),we foundby
RT-PCRasignificant shift towardageneexpressionprofile typical
of inflammatory M1macrophages (Figure 6J), which is consistent, October 20, 2015 ª2015 Elsevier Inc. 781
Figure 6. Itgax-DTA-Prf1–/– Chimeras Are
More Prone to HFD-Induced Inflammation
(A and B) 2 months after chimerism induction,
Itgax-DTA-Prf1/ (gray) and WT-Prf1/ (black)
chimeras were maintained on HFD and monitored
for weight change (numbers in A and percent in B)
over 90 days.
(C–E) Percent of body fat (C), liver weight (D), and
epididymal fat pad weight (E) in Itgax-DTA-Prf1/
(white) and WT-Prf1/ (black) chimeras main-
tained for 6 weeks on HFD (mean ± SD; *p < 0.05;
**p < 0.01).
(F–H) Amounts of leptin (F), IL-1b (G), and TNF-a
(H) were tested in sera of Itgax-DTA-Prf1/ (white)
and WT-Prf1/ (black) chimeras maintained on
high and low fat. Blood was drawn at different
time points, as indicated (mean ± SD; *p < 0.05,
***p < 0.001, nR 5).
(I) Serum cholesterol and TG in chimeric mice fed
HFD (mean ± SD, nR 5).
(J) Gene expression profile of M1 versus M2
genes determined by RT-PCR in VAT of Itgax-
DTA-Prf1/ (white) and WT-Prf1/ (black) chi-
meras, maintained on HFD for 2 months (mean ±
SD; *p < 0.05; **p < 0.01).
(K) Liver triglycerides in Itgax-DTA-Prf1/ (white)
and WT-Prf1/ chimera maintained for 6 weeks
on HFD (mean ± SD, nR 4).
(L) Serum insulin in Itgax-DTA-Prf1/ (white) and
WT-Prf1/ chimeras maintained for 6 weeks on
HFD (mean ± SD, nR 4).
Data are representative of three (A–F) or two
(G–L) independent experiments. See also Figures
S5–S7.with increased inflammatory properties ofmacrophages in the AT
of obese mice (Lumeng et al., 2007a; Weisberg et al., 2003).
It is possible that activation of T and NK cells upon onset of
inflammation or initiation of HFD might induce upregulation of
CD11c, and thereby of DT to a degree sufficient to cause the
deletion of these populations. Clearly, such deletion would not
be apparent in analysis of cell populations in the naive mice,
shown in Figure 1 prior to onset of disease. We therefore re-eval-
uated potential changes in the level of Prf1/-derived cells
within various leukocyte populations in the BM, spleen, and
VAT before (2 months after BMT) and after (7 months after
BMT) the onset of the metabolic phenotype. Likewise, we
analyzed such potential changes in chimeric mice after 8 weeks
of HFD, bywhich time the full-blown syndrome develops in Itgax-
DTA-Prf1/mice. As shown in Figures S6 and S7 and Table S1,
the relative abundance of the various cell types found in naive
mice remained unaltered after the inflammatory onset. These
findings are in line with previous observation, showing that
T cells from Itgax-DTA-Prf1/mice respond normally to antigen
challenge and are not deleted upon activation (Birnberg et al.,
2008).782 Immunity 43, 776–787, October 20, 2015 ª2015 Elsevier Inc.Perf-DCs Exhibit a Major
Regulatory Role in EAE
We showed that selective deletion of
perforin in the rare subpopulation of
perf-DCs leads to a distinct metabolicphenotype and that this phenotype can be prevented by T cell
depletion in vivo. This strongly indicates a role for perf-DCs in
the control of T-cell-mediated inflammatory processes. How-
ever, although we found a skewed TCR repertoire exhibited by
AT T cells in Itgax-DTA-Prf1/ chimeras, the identity of antigens
eliciting this inflammatory response are not known. To further
investigate the regulatory role of perf-DCs, we evaluated
whether perf-DCs might also exhibit a regulatory role in a
well-defined mouse model for autoimmunity, in which the path-
ological antigen is known. We therefore examined whether
Itgax-DTA-Prf1/ chimeras are more susceptible to develop-
ment of EAE, a T-cell-mediated disorder widely used as a model
of multiple sclerosis (Aharoni, 2013). In this mouse model, MOG-
induced EAE results in a chronic persistent disease course.
MOG administration in Itgax-DTA-Prf1/ mice resulted in a
greater clinical severity of the disease with earlier onset and
higher disease score (Figures 7A and 7B). Moreover, lymph
node cells from Itgax-DTA-Prf1/ mice showed more antigen-
specific proliferation of CD4+ T cells, both during the peak of
the disease at day 14 and during the chronic stage at day 30.
This specificity is clearly illustrated when comparing the marked
Figure 7. Perforin Deficiency within the DC
Population Results in Enhanced Suscepti-
bility to EAE
(A) Disease progression of Itgax-DTA-Prf1/
(red) and WT-Prf1/ (black) mice immunized with
MOG, and the average day of EAE onset (mean ±
SEM of two experiments with a total of 18 mice per
group).
(B) Spinal cord sections from the mice described
in (A), stained with hematoxylin and eosin (H&E);
arrows indicate inflammatory infiltrates. Scale
bars represent 10 mm.
(C and D) MOG-specific proliferation of spleno-
cytes from Itgax-DTA-Prf1/ (red) and WT-
Prf1/ (black) mice 30 days after immunization.
Proliferation was assessed by CFSE dilution
together with CD4 and CD8 antibody staining by
flow cytometry (***p < 0.001; mean ± SD, 5 mice
per group).
(E) Analysis of spinal cord T cells. T cells were
isolated from 3–5 pooled spinal cords from the
Itgax-DTA-Prf1/ or WT-Prf1/ mice, 14 days
after immunization with MOG, stimulated with
soluble CD3 overnight, and then stained for IL-17a
and IFN-g (mean ± SD; *p < 0.05, nR 3).
Data are representative of two independent
experiments.enhancement of anti-MOG CD4+ T cells to that exhibited by
T cells directed against PPD or MBP (Figure 7C) or of CD8+
T cells directed against MOG (Figure 7D). MOG-specific IFN-g-
and IL-17A-positive T cells were also found in the central nervous
system (CNS) 14 days after immunization (Figure 7E). These
results demonstrate the immune-regulatory role of perf-DCs
and the ability of these cells to inhibit detrimental expansion of
antigen-specific autoimmune clones in the context of EAE.
DISCUSSION
We have shown here that DCs expressing perforin represent a
subpopulation of regulatory DCs with a steady-state role in pre-
vention of inflammatory processes within the AT and in the CNS.
The intriguing relationship between metabolism and the immune
system has received increasing attention over the past few years
(Schipper et al., 2012). AT is now recognized as a true endocrine
organ that plays a fundamental role in controlling whole-bodyImmunity 43, 776–787glucose and lipid homeostasis (Guilherme
et al., 2008). Previous studies have identi-
fied various immune cells as metabolic
controllers with pathogenic or regulatory
potential (Chawla et al., 2011; Elgazar-
Carmon et al., 2008; Feuerer et al., 2009;
Kang et al., 2008; Liu et al., 2009; Lumeng
et al., 2007a, 2007b; Nguyen et al., 2007;
Nishimura et al., 2013; Odegaard et al.,
2007; Osborn and Olefsky, 2012; Taluk-
dar et al., 2012; Wu et al., 2011). Three
T lymphocyte subsets might play distinct
roles in AT immune homeostasis: CD8+
T cells (Nishimura et al., 2009), IFN-g+CD4+ T (Th1) cells (Rocha et al., 2008; Winer et al., 2009),
and Foxp3+ regulatory T (Treg) cells (Eller et al., 2011; Feuerer
et al., 2009; Ilan et al., 2010). In particular, the infiltration of
CD8+ T cells to the AT has been shown to precede macrophage
influx andM1polarization in the obese AT (Nishimura et al., 2009;
Rausch et al., 2008), and CD8+ T cells are involved in macro-
phage recruitment and polarization in obesity (Nishimura et al.,
2009). Furthermore, as also shown here, depletion of CD8+
T cells in obese mice improved insulin sensitivity, whereas
adoptive transfer of CD8+ T cells induces insulin resistance in
CD8-deficient mice (Nishimura et al., 2009).
A major drawback of most of these studies is the reliance on
HFD, which does not accurately represent normal steady-state
conditions in the AT. Our study showed the major impact of a
unique DC subpopulation on AT inflammatory processes in the
context of normal dietary conditions. The HFD regimen is asso-
ciated with further acceleration of disease onset in Itgax-DTA-
Prf1/ chimeras that lack perf-DCs and are susceptible to AT, October 20, 2015 ª2015 Elsevier Inc. 783
inflammation. Our observations of differences in TCRb reper-
toires of WT-Prf1/ versus Itgax-DTA-Prf1/ mice in both
adipose tissues tested (VAT and SC-AT), but not in the spleen,
suggest that specific T cells are missing from the adipose tissue
of WT-Prf1/ animals, potentially due to their deletion by regu-
latory perf-DCs. The possibility that the phenotype might be
mediated by antigen-specific T cells that escape regulation in
the absence of perf-DCs is supported by the observation that
the inflammatory AT phenotype can be completely prevented
by T cell depletion using either anti-CD4 or anti-CD8 antibodies.
As expected from previous studies in mice fed HFD (De Souza
et al., 2005), this inflammatory process is also accompanied by
late increase in IL-6 and IL-1B expression in the hypothalamus.
However, the late onset of this process in Itgax-DTA-Prf1/
chimeras indicates that it might be induced by the phenotype
rather than cause it.
In our chimeric mouse model, the T cell compartment must
reconstitute itself after transfer of BM to irradiated recipients.
Such reconstitution is slow, requiring about 2 months in mice.
Thus, we expect a delay in the replenishment of fat-resident
T cells at least of that magnitude, and possibly even longer,
due to slower traffic of T cells into the fat tissue. Only when
sufficient numbers of self-reactive T cells accumulate in the fat
tissue are inflammatory processes initiated.
Considering that DTA mice tend to develop a myeloprolifera-
tive disorder at old age, it could be argued that such a patholog-
ical process might be somehow associated with the phenotype
observed in our Itgax-DTA-Prf1/ chimera, which also develops
late after transplantation. However, we did not detect in our
chimeric mice any sign of myeloproliferative disorder, in line
with Birnberg et al. (2008), who showed in their original paper
that this phenotype did not develop in BM chimera established
by combining BM from DTA mice with BM from WT mice.
The Itgax promoter is also active in cells other than DCs,
including some NK cells, macrophages, and pDCs, although the
specific Itgaxpromoter fragmentused for the Itgax-cre transgenic
mice is inactive in certain cells (CD11cint moDCs, CD11cint PDCs,
and NK cells) that transcribe their endogenous Itgax alleles
(Bar-On and Jung, 2010). Nevertheless, we extensively evaluated
the possibility that our observed phenotype might be associated
withablationof thesecells inour Itgax-DTA-Prf1/chimera. Thus
we studied in our Itgax-DTA-Prf1/ and WT-Prf1/ chimeras
the expression of markers associated with NK cells (NK1.1,
NKp46, and CD49b(DX5)), macrophages (F4/80), and pDCs
(PDCA-1), and we confirmed the previous suggestion of Bar-On
and Jung (2010) that these cells, which express intermediate or
lowCD11c, arenotablatedbyDTA.Thus, they areequally derived
in the Itgax-DTA-Prf1/ chimera from both BM donors.
These results are in line with our previous work on perf-DCs
generated in vitro from hematoipoietic stem cells (HSCs),
negating the possibility of overlap between these cells and the
so-called natural killer dendritic cells (NKDCs) or interferon-
producing killer dendritic cells (IKDCs), previously reported to
exhibit dual NK and DC properties (Chan et al., 2006; Pillarisetty
et al., 2005; Taieb et al., 2006) or activated NK cells (Blasius et al.,
2007; Vosshenrich et al., 2007), as we demonstrated that perf-
DCs do not express markers typically associated with NK cells,
such as NK1.1, DX5, and NKp46, and are negative for B220,
which is expressed by IKDCs.784 Immunity 43, 776–787, October 20, 2015 ª2015 Elsevier Inc.It could be argued that if indeed ablation of perf-DCs is critical
for our observed phenotype, one would expect that Prf1/
mice, in which the mutation is expressed in every cell, would
be similarly susceptible to obesity. However, in such mice both
parts of the equation are impacted. Thus, not only perf-DCs,
but also perforin-positive effector T cells or NK cells critical for
inflammation, are missing, and therefore it is hard to predict
the overall outcome. In fact, in parallel to the submission of our
manuscript, a new study was published suggesting that Prf1/
mice exhibit enhanced obesity and some metabolic distur-
bances (Revelo et al., 2015). However, we observed only minor
weight gain with no increase in cholesterol or TG, and no
changes in the ability to handle glucose and insulin challenges
compared to WT mice (not shown).
Taken together, our results suggest that under physiological
conditions, perf-DCs probably induce deletion of specific self-
reactive T cells, potentially through presentation of tissue-spe-
cific self-antigens. In the case of adipose tissue, this leads to
deletion of tissue-resident T cells that have inflammatory capac-
ity, thereby contributing to immune tolerance. Thus, the appear-
ance of metabolic syndrome upon specific ablation of perf-DCs
in our experiments appears to be a consequence of reduced
deletion of those harmful T cells, resulting in adipose inflamma-
tion. Furthermore, our results strongly suggest that in the steady
state, a unique population of perf-DCs attenuates the severity of
EAE by specifically controlling CD4+ T cells that produce IL-17
and IFN-g upon activation by their cognate antigen.
The results shown in the present study collectively demon-
strate that perf-DCs exhibit an essential role in regulating the
delicate balance between immune cells and the fat tissue, and
consequently, the entire cascade leading tometabolic syndrome
and its associated type 2 diabetes. Thus, we suggest that future
therapies could operate by shifting the homeostatic balance of
perf-DC abundance and that of other immune cell populations,
and their activation state. This might be attained either by inhib-
iting their ecological competitors or by giving them a growth or
accumulation advantage. Our insights regarding the role of
perf-DCs might offer opportunities for new rational therapeutics,
directed not only at controlling aberrant T cell clones, but also at
addressing the regulatory possibilities offered by perf-DCs.
Perforin deficiency within the myeloid DC population results
in enhanced susceptibility to EAE. Therefore, perf-DCs might
represent, in addition to Treg cells, a regulatory cell population,
critical for protection from autoimmunity and AT inflammatory
processes. Further studies of these regulatory cells in normal
human subjects and in patients is required to establish the
translational value of our findings, which could potentially lead
to important therapeutic approaches.EXPERIMENTAL PROCEDURES
Animals
Mice were 6- to 12-week-old females or males of the following strains: C57BL/
6, Itgax-DTA, and Prf1/ (Weizmann Institute Animal Breeding Center). BM
chimeras were generated by exposure of C57BL/6 WT mice to a single dose
of 950 rad total body irradiation. The following day, the mice received 5 3
106 mixed BM cells i.v., as indicated. Animals were maintained under condi-
tions approved by the Institutional Animal Care and Use Committee at the
Weizmann Institute of Science. In some experiments, mice were maintained
on high-fat diet as detailed in the Supplemental Experimental Procedures.
Metabolic Studies
Itgax-DTA-Prf1/ and WT-Prf1/ chimeric mice were weighed regularly.
Tests for glucose and insulin tolerance, glucose, triglycerides, total
cholesterol, high-density lipoprotein (HDL), and cytokine serum levels
(measured by ELISA kits) are detailed in the Supplemental Experimental Pro-
cedures. Body composition analysis was performed by EchoMRI Analyzer
(EchoMRI).
Fat-Associated SVF Cell Isolation
VAT and inguinal SC pads were mashed into small pieces, and single-cell sus-
pensions were prepared by collagenase digestion, as detailed in the Supple-
mental Experimental Procedures.
Histology, Immunohistochemistry, and Cytofluorometric Analysis
Tissue samples from spinal cord and visceral adipose tissue were fixed, pro-
cessed, and embedded in paraffin. Sections of 5 mm were stained with hema-
toxylin and eosin (H&E). Fat cell area onH&E-stained slideswasmeasuredwith
ImageJ software as detailed in the Supplemental Experimental Procedures.
Staining of perforin to identify perf-DCs is described in the Supplemental
Experimental Procedures. In brief, splenic DCs from WT and Prf1/ mice
were isolated by two-stage magnetic sorting and were spun onto glass slides
and fixed with 4% PFA. The cells were then blocked first with 5% horse serum
and 0.2% Triton for 5 min, and subsequently with 100% horse serum for 1 hr.
Isotype blocking was done with rat IgG2a overnight in 25% horse serum and
0.1% Triton at 4C followed by secondary anti-RatCy2 or anti-Rat DyLight594
(Jackson) antibody to visualize the non-specific binding. Specific rat anti-
perforin Ab (Clone CB5.4, Abcam) was applied overnight in 25% horse serum
and 0.1% Triton at 4C followed by secondary anti-rat DyLight 594 or anti-rat
AMCA (Jackson) antibody. The nuclei were stained with Hoechst blue or
yellow stain. Flow cytometry and analysis are outlined in the Supplemental
Experimental Procedures.
Depletion of CD4+ and CD8+ T Cell Populations
Anti-CD4 or -CD8 depleting antibodies were administered i.p. weekly, as
detailed in the Supplemental Experimental Procedures.
RNA Extraction, Quantitative RT-PCR for AT, and TCRb Sequencing
Total RNA from fat pads was extracted and reverse-transcribed as detailed in
the Supplemental Experimental Procedures. Total RNA was extracted from
spleen, visceral adipose tissue, and subcutaneous adipose tissue of DTA-
PKO and WT-PKOmice. The TCRb sequencing procedure and computational
analysis are detailed in the Supplemental Experimental Procedures.
EAE Induction and Evaluation
Chronic EAE was induced in C57BL/6 chimeric mice by injecting a peptide
consisting of amino acids 35–55 of myelin oligodendrocyte glycoprotein
(MOG) as detailed in the Supplemental Experimental Procedures. Mice were
examined daily and EAE was scored as follows: 0, no disease; 1, limp tail; 2,
hind limb paralysis; 3, paralysis of all limbs; 4, moribund condition; and 5,
death.
CFSE Proliferation Assay of CD4+ and CD8+ T Cells
Isolated lymph node cells from chimericmice 14 or 30 days after EAE induction
were isolated and stained with 5 mM CFSE (CellTrace CFSE Cell Proliferation
Kit, Invitrogen) for 15 min. Proliferation in response to different stimuli was
assessed, as detailed in the Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures, two tables, and Supple-
mental Experimental Procedures and can be found with this article online at
http://dx.doi.org/10.1016/j.immuni.2015.08.015.
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